title: Approve bevacizumab for use in eye disease in cash strapped times.
authors: Ilias
authors: I
authors: Georgalas
authors: Chrysanthi
authors: C
authors: Koutsandrea
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics* / Q000627:therapeutic use; D000068258:Bevacizumab; D017277:Drug Approval; D016527:Drug Costs; D006801:Humans; D012164:Retinal Diseases / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab